GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » EPS (Diluted)

Visioneering Technologies (ASX:VTI) EPS (Diluted) : A$-0.15 (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies EPS (Diluted)?

Visioneering Technologies's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was A$-0.07. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.15.

Visioneering Technologies's EPS (Basic) for the six months ended in Dec. 2023 was A$-0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.15.

Visioneering Technologies's EPS without NRI for the six months ended in Dec. 2023 was A$-0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.15.

During the past 3 years, the average EPS without NRIGrowth Rate was 55.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 60.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Visioneering Technologies's highest 3-Year average EPS without NRI Growth Rate was 76.00% per year. The lowest was 51.30% per year. And the median was 58.10% per year.


Visioneering Technologies EPS (Diluted) Historical Data

The historical data trend for Visioneering Technologies's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies EPS (Diluted) Chart

Visioneering Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -5.81 -1.65 -0.15 -0.34 -0.15

Visioneering Technologies Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.19 -0.15 -0.08 -0.07

Competitive Comparison of Visioneering Technologies's EPS (Diluted)

For the Medical Devices subindustry, Visioneering Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visioneering Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's PE Ratio falls into.



Visioneering Technologies EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Visioneering Technologies's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-5.156-0)/34.852
=-0.15

Visioneering Technologies's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.474-0)/38.173
=-0.06

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visioneering Technologies  (ASX:VTI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Visioneering Technologies EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Visioneering Technologies (ASX:VTI) Business Description

Traded in Other Exchanges
N/A
Address
10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.

Visioneering Technologies (ASX:VTI) Headlines

From GuruFocus

Top 5 4th Quarter Trades of Greenfield Savings Bank

By GuruFocus Research GuruFocus Editor 01-13-2023

HERITAGE INVESTORS MANAGEMENT CORP's Top 5 Buys of the 4th Quarter

By GuruFocus Research GuruFocus Editor 02-06-2023

Carl P. Sherr & Co., LLC Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-03-2023

Top 5 3rd Quarter Trades of Gibson Wealth Advisors LLC

By GuruFocus Research GuruFocus Editor 11-23-2022

McClarren Financial Advisors, Inc. Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-31-2023

PrairieView Partners, LLC Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-31-2023

Top 5 4th Quarter Trades of Foster Group, Inc.

By GuruFocus Research GuruFocus Editor 01-24-2023

Top 5 4th Quarter Trades of H&H Retirement Design & Management INC

By GuruFocus Research GuruFocus Editor 01-17-2023

GP Brinson Investments LLC Buys 4, Sells 1 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-06-2023

D'Orazio & Associates, Inc. Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-26-2023